文献速递外周动脉疾病

膝下动脉病变首次血运重建策略:旁路与腔内治疗的围术期结局

Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.
PubMed 文献 · J Vasc Surg · 2017-08-24

该研究基于NSQIP血管模块2011-2014年数据,纳入5998例非急诊首次膝下动脉血运重建患者,比较旁路手术与腔内治疗的围术期结局。在CLTI和跛行患者中,腔内优先策略30天死亡率无差异,但主要不良心血管事件、手术部位感染、出血、非计划再手术和再入院率更低,代价是CLTI患者30天二次血运重建率更高。

要点

  • 腔内优先策略在CLTI和跛行患者中30天死亡率与旁路手术无差异
  • 腔内优先策略降低CLTI和跛行患者的主要不良心血管事件、手术部位感染、出血、非计划再手术和再入院风险
  • 腔内优先策略增加CLTI患者30天二次血运重建率,跛行患者未见显著增加

核心结论

  • 腔内优先策略治疗膝下动脉病变与较低的早期并发症相关,但死亡率无差异,代价是CLTI患者术后二次血运重建率更高。
  • 作为全国性首次血运重建的代表,该研究强调了腔内治疗的早期围术期获益,但需更可靠的长期数据来决定特定患者的最佳策略。

研究设计与样本

  • 回顾性队列研究,使用NSQIP Targeted Vascular模块2011-2014年数据,纳入5998例非急诊首次膝下动脉血运重建患者。
  • 按症状状态分层为CLTI或跛行,比较腔内治疗与旁路手术,采用多变量逻辑回归评估患者选择和术后结局。

主要发现

  • 5998例首次膝下动脉血运重建中,旁路手术3193例(63%为CLTI),腔内治疗2805例(64%为CLTI)。
  • CLTI患者中,腔内优先策略与旁路手术相比,30天死亡率无差异(单变量2.1% vs 2.2%;调整后OR 0.7,95%CI 0.4-1.1)。
  • 跛行患者中,腔内优先策略与旁路手术相比,30天死亡率无差异(0.3% vs 0.6%)。
  • CLTI患者中,腔内优先策略与较低的主要不良心血管事件(3.6% vs 4.7%;OR 0.6,95%CI 0.4-0.9)、手术部位感染(0.9% vs 7.7%;OR 0.1,95%CI 0.1-0.2)、出血(8.5% vs 17%;OR 0.4,95%CI 0.3-0.5)、非计划再手术(13% vs 17%;OR 0.7,95%CI 0.5-0.8)和再入院(17% vs 18%;OR 0.8,95%CI 0.7-0.9)相关。
  • 跛行患者中,腔内优先策略与较低的主要不良心血管事件(0.8% vs 1.6%;OR 0.4,95%CI 0.2-0.95)、手术部位感染(0.7% vs 6.6%;OR 0.1,95%CI 0.04-0.2)、出血(2.3% vs 6.0%;OR 0.3,95%CI 0.2-0.5)、非计划再手术(4.3% vs 6.6%;OR 0.6,95%CI 0.4-0.9)和再入院(5.9% vs 9.0%;OR 0.6,95%CI 0.4-0.8)相关。

关键数值与推荐

  • CLTI患者中,与腔内优先策略相关的特征包括年龄≥80岁、组织缺损、不吸烟、功能依赖、糖尿病、透析和胫动脉病变。
  • 跛行患者中,与腔内优先策略相关的特征包括年龄≥80岁、非白人种族、不吸烟、糖尿病和胫动脉病变。

临床怎么用

  • 对于膝下动脉病变首次血运重建的患者,腔内优先策略可降低早期并发症风险,但CLTI患者需权衡二次血运重建风险。
  • 患者选择应综合考虑年龄、症状状态、合并症和病变特征,长期疗效仍需进一步研究。

局限性

  • 研究为回顾性设计,仅反映围术期结局,缺乏长期随访数据。
  • 数据来自NSQIP,可能存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The optimal initial revascularization strategy remains uncertain for patients with peripheral arterial disease. The purpose of this study was to evaluate current nationwide selection and perioperative outcomes of patients undergoing bypass or endovascular intervention for infrainguinal disease in those with no prior ipsilateral revascularization. METHODS: Patients undergoing nonemergent first-time infrainguinal revascularization were identified in the Targeted Vascular module of the National Surgical Quality Improvement Program (NSQIP) for 2011 to 2014 and stratified by symptom status (chronic limb-threatening ischemia [CLTI] or claudication). Patients treated with endovascular intervention were compared with those who underwent bypass. Multivariable logistic regression was used to evaluate current selection of patients and to establish independent associations between first-time procedures and postoperative outcomes. RESULTS: Of 5998 first-time infrainguinal revascularizations performed, 3193 were bypass procedures (63% for CLTI) and 2805 were endovascular interventions (64% for CLTI). Current patient characteristics associated with an endovascular-first approach as opposed to bypass-first in CLTI patients were age ≥80 years, tissue loss, nonsmoking, functional dependence, diabetes, dialysis, and tibial lesions, whereas age ≥80 years, nonwhite race, nonsmoking, diabetes, and tibial lesions were associated with an endovascular approach for claudication. In comparing first-time endovascular intervention with bypass, there was no difference in 30-day mortality in CLTI patients (univariate: 2.1% vs 2.2%; adjusted: odds ratio [OR], 0.7; 95% confidence interval [CI], 0.4-1.1) or claudication patients (0.3% vs 0.6%). Among CLTI patients, endovascular-first intervention was associated with lower rates of major adverse cardiovascular event (3.6% vs 4.7%; OR, 0.6; 95% CI, 0.4-0.9), surgical site infection (0.9% vs 7.7%; OR, 0.1; 95% CI, 0.1-0.2), bleeding (8.5% vs 17%; OR, 0.4; 95% CI, 0.3-0.5), unplanned reoperation (13% vs 17%; OR, 0.7; 95% CI, 0.5-0.8), and unplanned readmission (17% vs 18%; OR, 0.8; 95% CI, 0.7-0.9). Patients with claudication undergoing endovascular-first intervention also had lower rates of major adverse cardiovascular event (0.8% vs 1.6%; OR, 0.4; 95% CI, 0.2-0.95), surgical site infection (0.7% vs 6.6%; OR, 0.1; 95% CI, 0.04-0.2), bleeding (2.3% vs 6.0%; OR, 0.3; 95% CI, 0.2-0.5), unplanned reoperation (4.3% vs 6.6%; OR, 0.6; 95% CI, 0.4-0.9), and unplanned readmission (5.9% vs 9.0%; OR, 0.6; 95% CI, 0.4-0.8). Conversely, endovascular-first intervention was associated with a higher rate of secondary revascularizations within 30 days for CLTI (4.3% vs 3.1%; OR, 1.6; 95% CI, 1.04-2.3) but not for claudication (2.6% vs 1.9%; OR, 1.7; 95% CI, 0.9-3.4). CONCLUSIONS: An endovascular-first approach as a revascularization strategy for infrainguinal disease was associated with substantially lower early morbidity but not mortality, at the cost of higher rates of postoperative secondary revascularizations. As a national representation of first-time revascularizations, this study highlights the early endovascular perioperative benefit, although more robust long-term data are needed to adopt either one strategy or the other in select patients with peripheral arterial disease.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bodewes TCF, Darling JD, Deery SE, et al. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease. J Vasc Surg. 2017. PMID: 28844467. doi:10.1016/j.jvs.2017.05.132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。